However, some customers experienced delivery delays/issues with losing their prescription, and some customers thought that the customer support team was less responsive in dealing with prescriptions and insurance issues In short, Mochi is a good platform for patients who desire a genuine specialist-level obesity medicine care and who want a comprehensive formulary that covers both brand-name and compounded options, and real insurance navigation support
Early phase 2 clinical data, including a 2023 publication in the New England Journal of Medicine , suggest retatrutide may produce substantial weight loss
patients enjoy improvements in their attention span
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)
Additionally, Saxenda can cause changes in digestive patterns and gut motility